AMICAS Announces General Availability of AMICAS PACS Version 6.0 at ...( Leader in image and information softw...),Health
Navigation Links
AMICAS Announces General Availability of AMICAS PACS Version 6.0 at HIMSS 2009
Date:4/3/2009
Leader in image and information software continues to deliver innovation to meet market needs
BOSTON, April 3 /PRNewswire-FirstCall/ -- AMICAS, Inc. (Nasdaq: AMCS), a leader in image and information management solutions, will announce the general availability of AMICAS PACS(TM) Version 6.0 at the HIMSS '09 Annual Conference and Exhibition in Chicago, which takes place from April 4 to 8. AMICAS will also display the full portfolio of imaging IT solutions for hospitals and ambulatory imaging businesses at HIMSS '09.
(Logo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO )
AMICAS PACS Version 6.0, which will be generally available in April, introduces intrinsic 3D, sophisticated mammography workflow, advanced personalization and hanging protocols, and patient-centric reading to the imaging marketplace.
Version 6.0 introduces the next generation of AMICAS PACS, and will combine the intuitive, easy-to-use, Web-based design of previous versions of AMICAS PACS with major enhancements to the image viewing toolset. Complementing the industry leading, workload balancing RealTime Worklist(TM), Version 6.0 will introduce the Halo Viewer(TM), including advances in functionality aimed at increasing radiologist productivity and designed to help improve the quality of reading.
With Version 6.0's intrinsic 3D and mammography workflow tools, radiologists will be able to interpret a wide variety of exam types -- all within a single viewer. These new tools are designed to provide increased efficiency by allowing radiologists to interpret an increasing percentage of their interpretation workload within their normal workflo
'/>"/>
| SOURCE AMICAS, Inc. Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
2. AMICAS Hosts Complimentary DRA Education Session Featuring Timothy Trysla
3. AMICAS to Present at William Blair & Company Small Cap Growth Stock Conference
4. AMICAS Schedules Third Quarter Earnings Call
5. Radiology Ltd. Chooses AMICAS as End-to-End Solutions Provider
6. Webcast Alert: AMICAS, Inc. Announces 3rd Quarter 2007 Earnings Conference Call
7. AMICAS Launches Vision Reach 2.0, a Tool to Help Radiology Businesses Grow
8. AMICAS Transforms Critical Results Notification with RadStream
9. AMICAS Solutions Closing the Loop in Radiology Communications
10. MedQuest Standardizes on AMICAS Vision Series PACS
11. AMICAS to Present at UBS Global Healthcare Services Conference
Post Your Comments:
(Date:12/2/2009)..., , JOHANNESBURG, Dec. 2 Le...(over US$6 million) investment in AllLife, the inn...g with HIV and diabetes. The investment brings tog...ent fund, and AllLife, one of Africa,s most innova...lace after World AIDS Day. ,, "AllLife has deve...
(Date:12/2/2009)...CHICAGO A randomized, controlled study comparing ...ive treatment called percutaneous disc decompressi...both treatments help patients in the short run, on...o two years later. Results of the study, the first...eeting of the Radiological Society of North Americ...
(Date:12/1/2009)... Advocate Christ Medical Ce...s newest kidney transplant center and the first fo...lowing formal approval of the hospital’s pla...ities and Services Review Board. , ...hrist Medical Center in Oak Lawn, Ill. has become...
(Date:12/1/2009)..., , NEW YORK, Dec. 1 R...ch report is available in its catalogue: ,, E...ynamics and the changing healthcare and regulatory...p0165660/Emerging-Clinical-Trial-Locations---India...egulatory-environment.html ,, Over the last de...
(Date:12/1/2009)..., , WASHINGTON, Dec. 1 /PRNewswire-USNewswire...medicine clinic in Los Angeles, has agreed to pay ... that it received illegal kickbacks from HealthSou...oday. ,, The settlement resolves allegatio...in the form of stock option grants, donations to t...
Breaking Medicine News(10 mins):Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 2Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 3Health News:Outpatient disc treatment gives long-term back pain relief 2Health News:State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 2Health News:State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 3Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Health News:Los Angeles' Kerlan Jobe Orthopaedic Clinic Pays $3 Million to Settle Kickback Allegations 2[0] LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer[0] Outpatient disc treatment gives long-term back pain relief[1] State Approves Plans For Kidney Transplants At Advocate Christ Medical Center [2] Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment[0] Los Angeles' Kerlan Jobe Orthopaedic Clinic Pays $3 Million to Settle Kickback Allegations
...cademy,of Family Physicians is pleased that Presid... interest in improving access to health care. In d...te about health system reform., Improving America...se who provide those services and reins in the,spi...
...ia,Nurses Association/National Nurses Organizing C... Committee for resisting enormous pressure to,pass...k with legislators,community groups, and labor for...oro congratulated the committee "for its thorough,...
...tric Medical, Inc.,announced today that it has obt... Merci L6 Retrievers in the European Union. These ...07, join the existing Merci,Retrievers(R) already ...i L4 and L6 Retrievers join Concentric Medical,s L...
...ng a nasty cough is now a lot easier thanks to a n...s just been approved by U.S. Food and Drug Adminis...s new test simultaneously detects the most prevale...Dr. James Mahony, in conjunction with Luminex Mole...
...otection in future , , MONDAY, Jan. 28 (He...e tongue might one day ward off the flu. , Not onl..., be more convenient, it also appears to be more e...d of needles, but it,s clearly an introductory stu...
...ton,Dickinson and Company) (NYSE: BDX ), a global...t would present at the Merrill Lynch Global,Pharma...nce on Thursday,February 7, 2008 at 10:20 a.m. (ET...play,through Thursday, February 14, 2008., BD, a ...
Other Medicine News:Health News:AAFP Statement - Family Physicians to President Bush: Call for Improved Health Access is Only One Step to Comprehensive Reform 2Health News:AAFP Statement - Family Physicians to President Bush: Call for Improved Health Access is Only One Step to Comprehensive Reform 3Health News:RNs Praise Courageous Vote by Senate Committee on Badly Flawed Healthcare Bill 2Health News:RNs Praise Courageous Vote by Senate Committee on Badly Flawed Healthcare Bill 3Health News:Concentric Medical Announces European Release of Expanded Family of Neurovascular Retrievers for use in Stroke Patients 2Health News:McMaster test detects the most prevalent respiratory viruses 2Health News:Drop of Flu Vaccine Under Tongue Bars Infection 2AAFP Statement - Family Physicians to President Bush: Call for Improved Health Access is Only One Step to Comprehensive ReformRNs Praise Courageous Vote by Senate Committee on Badly Flawed Healthcare BillConcentric Medical Announces European Release of Expanded Family of Neurovascular Retrievers for use in Stroke PatientsMcMaster test detects the most prevalent respiratory virusesDrop of Flu Vaccine Under Tongue Bars InfectionBD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
(Date:12/1/2009)... , NASHVILLE, Tenn., Dec. 1 /PRNewswire-First... CPIX ) announced today that an independently cond...ion, or intravenous N-acetylcysteine, as a cost-sa...lished in Volume 12, Number 4 of the peer-reviewed...December. The study concludes that Acetadote is a ...
(Date:12/1/2009)..., ARLINGTON, Va., Dec. 1 BioInf...report, The Market Outlook for Research Products... to the NIH Scientific Research program by the Ame...g earmarked for lab renovations, Challenge Grants,...hat spans multiple public and non-profit instituti...
(Date:12/1/2009)..., MORRISVILLE, N.C., Dec. 1 nCon...investigation of devices for minimally-invasive tr...initiation of a feasibility clinical trial designe...d surgical and catheter procedure, the convergent ...smal atrial fibrillation (AF). This prospective, ...
Breaking Medicine Technology:Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 2Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 3Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 4Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 5Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 6BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010 2BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010 3nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 2Scientific Paper Supports Micro Bland Embolization Technique for Liver Cancer With Embozene 28TM 29 Microspheres 58913 1Scientific Paper Supports Micro Bland Embolization Technique for Liver Cancer With Embozene 28TM 29 Microspheres 58913 2Running a Marathon The realbuzz com Beginners Guide 58910 1Running a Marathon The realbuzz com Beginners Guide 58910 2Running a Marathon The realbuzz com Beginners Guide 58910 3News briefs from the October issue of Chest 58908 1News briefs from the October issue of Chest 58908 2[0] Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems[0] BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010[0] nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure
...sts for Skin and Soft Tissue Infection and Blood C... Healthcare Acquired Infections, SUNNYVALE, Calif...the European release of Xpert(TM) MRSA/SA-Blood,Cu...ssue Infection (SSTI),tests as European CE IVD Mar...o Diagnostic Medical Devices. The tests are design...
...sults Set Stage for Development of Sustainable, Or...Fish Feeds, BOCA RATON, Fla., Dec. 4 Neptune Ind...neration aquaculture technology,company with diver...food,science, sustainable seafood, waste-to-energy...products, announced today that Phase II trials on,...
Other Medicine Technology:Cepheid Launches New GeneXpert(R) Tests in Europe for Simultaneous, Rapid Detection of Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus 2Cepheid Launches New GeneXpert(R) Tests in Europe for Simultaneous, Rapid Detection of Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus 3Neptune Industries Reports Favorable Phase II Trial Results on Ento- Protein(TM) 2Neptune Industries Reports Favorable Phase II Trial Results on Ento- Protein(TM) 3Neptune Industries Reports Favorable Phase II Trial Results on Ento- Protein(TM) 4| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |